Carregant...
RAS-MAPK signaling influences the efficacy of ALK-targeting agents in lung cancer
ALK (anaplastic lymphoma kinase) inhibitors are approved in for ALK gene rearrangement positive (ALK+) lung cancer, but resistance remains a challenge. We discovered that RAS-RAF-MEK-ERK signaling controls the ALK inhibitor response in ALK+ lung cancer and is critical for ALK inhibitor resistance. U...
Guardat en:
| Publicat a: | Mol Cell Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905399/ https://ncbi.nlm.nih.gov/pubmed/27308613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1091061 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|